ZEVRA THERAPEUTICS, INC. 8-K

What Happened
On May 6, 2026, Zevra Therapeutics, Inc. announced its financial results and corporate updates for the quarter ended March 31, 2026 via a press release and scheduled a conference call and audio webcast for Wednesday, May 6, 2026 at 4:30 p.m. ET to discuss the results. The press release was furnished as Exhibit 99.1 to the Form 8-K.

Key Details

• Press release dated May 6, 2026 announcing quarterly results for the period ended March 31, 2026 (furnished as Exhibit 99.1).
• Conference call and audio webcast scheduled for May 6, 2026 at 4:30 p.m. Eastern Time.
• The press release is furnished (not “filed”) under the Exchange Act and is not incorporated by reference for purposes of Section 18.
• Interactive XBRL cover page (Exhibit 104) was included with the filing.

Why It Matters
This filing signals that Zevra has released its quarterly earnings and corporate updates and is providing a live forum (call/webcast) for investors to hear management commentary. Retail investors should review the press release and listen to the webcast for details on revenue, earnings, guidance, or strategic updates; note that the press release furnished here is informational and has limited legal incorporation into other filings. For full audited or detailed financial statements and management discussion, investors should watch for the company’s subsequent periodic filings (e.g., quarterly reports).